EdiLabs OÜ

EdiLabs is an Estonian biotechnology company focused on developing a novel edible biologics platform. The company aims to overcome traditional barriers in biologic manufacturing and delivery—such as high costs, cold-chain requirements, and invasive administration—by leveraging plant-based expression systems to create scalable, accessible therapeutics. The company operates as a preclinical-stage research entity, emphasizing a multidisciplinary approach that integrates neuroscience, plant biology, and immunology. EdiLabs is currently part of the healthtech ecosystem in Estonia and is actively seeking strategic partnerships and investment to advance its pipeline, which includes early-stage immunotherapy candidates for conditions like Alzheimer's disease.